Louisiana Medical Cannabis Foundational Certification
MM411 has transitioned to a subscription model. You now receive more educational value for less money. As part of the new MM411 subscription for $160 annually, you will receive access to the Masters of Medical Cannabis Certification, Advanced CBD Certification, and all other courses. Pick any course as part of the annual subscription.
What’s in Store for MM411 Subscribers?
Our subscribers, fondly known as MM411 Scholars, will gain:
– Expert certifications added monthly on topics of cannabis compliance, science, how to medicate and much more!
– Downloadable Infographics & Videos
– A community of scholars who also share your passion for learning
– 100% guarantee from the most trusted cannabis education company, MM411
Our Vision Behind the Economical Subscription:
At the heart of this innovation is our conviction that the industry demands a sustainable economic model. We believe in championing the emerging science of cannabis education, bolstering compliance management for industry professionals, and fostering a space for thought leadership through group communication. Our new subscription pricing is not just about affordability; it’s a reflection of our commitment to creating a robust ecosystem for cannabis education and industry advancement.
Since 2009, we’ve been committed to equipping the cannabis industry with top-notch knowledge. Chances are, many of your proficient employees have already benefited from our programs!
Does your state have legal medical marijuana? Yes. Per Act 491 and Act 492 of the 2022 Regular Legislature, as of August 1, 2022, the Louisiana Department of Health has assumed regulatory authority over Louisiana’s medical (therapeutic) marijuana program. LDH personnel are responsible for conducting inspections of medical marijuana production facilities and reviewing finished product test results to verify compliance with the requirements of La. R.S. 40: 1046. While there will be some changes to the way that the program is administered, the department is working with its counterparts at the Louisiana Department of Agriculture and Forestry to ensure a smooth transition.
What does the Certification Include?
The Medical Cannabis Foundational Certification will allow you to learn the core fundamentals of cannabis science and explore cannabis industry knowledge, so you are prepared to be a certified in your state. Our courses and certifications will provide you with knowledge and skillset to enter the cannabis job market competitively, right out of the gate. This certification is not just for medical professionals, but for budtenders who want to enroll in the most robust cannabis certification course as your educational foundation.
As you expand your cannabis educational pursuits, make sure to check out additional courses such as our Advanced CBD Certification. Medical Marijuana 411 will be adding new expert level certifications monthly. Subscribe to our e-news to stay informed!
The Medical Cannabis Foundational Course is an online course that covers a series of 12 modules designed to teach healthcare and industry professionals the fundamental topics of cannabis and includes a specific module on the legal framework, forms and other pertinent information regarding the Louisiana Medical Marijuana program.
In addition to Louisiana specific Medical (Therapeutic) Marijuana regulations, you will learn about the federal legal framework of working with medical marijuana patients, the basics of the cannabis plant, the Endocannabinoid System, and how cannabinoid receptors work with our bodies. Learn about in 2015, the legislature amended the existing law and put in place the mechanisms and statutory framework for growing, distributing and recommending therapeutic marijuana (TM). Additional modules will cover important topics like: how to medicate, inhalation versus ingestion, contraindications, drug-on-drug interactions, and recommended rations of specific illnesses.
Did you know? Healthcare Professionals are covered by Federal Law to talk to patients about Medical Marijuana even in non-legal states by an existing statute? That’s the wealth of information contained in MM411, Inc. certifications.
This certification also includes: video testimonials from scientists and medical experts, downloadable infographics, additional visuals to support the written content followed by an exam to receive your certificate. Any individual wanting to learn more about the science of cannabis will find the course valuable. And we guarantee your complete satisfaction or your money back. To date, MM411, Inc has never had a return. Enrollees love our certifications and we stand by our courses with a 100% guarantee.
Module 1 – US Legal
- U.S. Controlled Substances Act
- Drug Schedule – Cannabis Schedule I
- Drug Schedule (Graphic)
- COVID Cannabis Guidelines
- Economic Impact
- Cannabis genus of flowering plants in the family Cannabaceae
- Legal differentiation between hemp and marijuana distinguished by their respective concentrations of the cannabinoid delta-9 tetrahydrocannabinol (THC)
- 2018 Farm Bill
- Impact on hemp classification
- SAFE Banking Act
- U.S. Pat. No. 6,630,507
- Ogden Memo
- Cole Memo
- Wilkenson Memo
- 2018 Sessions Memorandum
- Rohrabacher–Blumenauer Amendment
- Joyce Amendment
- Conant v. Walters
- What Medical Professionals Can Legally Provide To Their Patients (Graphic)
- Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research
- Guidance for Industry – Downloadable PDf
- Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research
- Guidance for Industry – Video Explainer
- Affirmative Defense
- Bankruptcy Protection
- Employment Law
- Access to Banking – Financial Crimes Enforcement Network FinCEN Guidance
- Copyright and Registration
Module 2 – Louisiana Medical (Therapeutic) Marijuana Legal
Module 3 – History
- Early History of Cannabis Use
- Cannabis in the West
- U.S. Prohibition History
- The Medical Implications of U.S. Prohibition
- Medical Cannabis Today
- Hemp vs Cannabis
- Brief Chronology of History in Spain and throughout Europe
Module 4 – The Discovery of the Endocannabinoid System
- Introduction of the Endocannabinoid System (ECS)
- Largest Receptor System
- ECS – Video Explainer
- Newly Discovered
- Chemical Bridge to All Bodily Functions
- Healthy Body = Healthy ECS
- ECS – Downloadable Graphic
- Dr Jake Felice – What is the Endocannabinoid System (ECS)? Video Interview
- Largest Neurotransmitter System of all “the body’s supercomputer”
- 1964 discovery of THC and CBD – Raphael Mechoulam, Ph.D and Yehiel Gaoni, Ph.D
- The Scientist – video regarding Raphael Mechoulam, Ph.D discoveries
- Allyn Howlett, Ph.D – Isolating THC in the brain – 1998
- No cannabinoid receptors in the cardiac and respiratory centers of the brainstem therefore no overdose from cannabis
- Raphael Mechoulam, Ph.D found in 1992, brain chemical that mirrors the effects of THC
- Two brain chemicals – anandamide, Sanskrit word “ananda” brain chemical that mimics THC and CBD, 2-Arachidonoylglycerol, which they named 2-AG.
- Endogenous Molecules “endocannabinoids”.
- CB1 receptors, and CB2 receptors
- Cannabinoids and how they attach to receptors
- CB1 receptors
- Located in the central nervous system and affect many brain functions including movement, anxiety, stress, fear, pain, appetite, reward, and motor control
- CB2 receptors
- CB2 receptors control the release of cytokines, immuno-regulatory proteins, that are linked to inflammation during illness or after injury.
- Retrograde Inhibition
- Lack of education on the Endocannabinoid System
- Clinical Studies
- At a Glance – Downloadable Infographic
- Human Thriving Behavior and the ECS
Module 5 – One Plant, One Complex Chemical Factory
- Minor Cannabinoids: CBG CBC CBN THCV
- The Entourage Effect & Tolerance / ECS Down Regulation
- Botanical vs. Single Molecule Compounds & Cannabinoids and Opioids
Module 6 – Getting Cannabinoids into the Bloodstream
- Inhalation: Smoking vs. Vaporization
- In the News Discussions
- Cannabis Flower vs. Concentrate
- Different Concentrate Consistencies
- Extraction Methods
- Concentrates Using Solvents
- Solventless Concentrates
- Edibles, Oral Mucosal, Topicals and Suppositories
- The Role of the Medical Provider
- The Role of the Dispensary: Experts within the Dispensary
Module 7 – Patient Centered Dosing
- Considerations Before Medicating with Cannabis
- Set and Setting
- Drug-Drug Interactions
- Relative Contraindications
- Youth Under 25
- Patients and Cardiac Conditions
- Patients with Psychiatric Diagnoses
- Immunocompromised Patents
- Biphasic Effect
- Finding the Appropriate Dose
- Recommended Ratios for Specific Illnesses
Module 8 – Laboratory Testing
- How Testing Works
- Contaminants: Pesticides, Fungi and Mold
- How to Interpret a Test
Module 9 – Clinical Practice
- Anxiety Disorders
- Gastrointestinal Disorders
- Migraine Headaches
- Multiple Sclerosis
- Neurodegenerative Disorders
- Palliative Care
- Parkinson’s Disease
- Post Traumatic Stress Disorders
- Sleep Disorders
- Traumatic Brain Injury (TBI)
- Premenstrual Syndrome and Premenstrual Dysphoric Disorder
Module 10 – Cannabis and Opioids
- Pain Management Today
- Cannabis and Opioids: The Good News
- Cannabis and NSAIDS: More Good News
Module 11 – Medical Myths and Facts
- Gateway Theory, Addiction and Brain Function
- Impaired Motivation, Memory and Mental State
- Lung Damage, Usage Patterns and Overall Danger
Module 12 – Side Effects Abuse and Misuse
- Cannabinoid Hyperemesis Syndrome
- Cannabis Use Disorder (CUD)
- Short and Long Term Side Effects
- Physical and Mental Effects
- Cannabis and driving
- Cannabis Overconsumption and Tolerance
Louisiana–Medical (Therapeutic) Marijuana Legal Overview
Per Act 491 and Act 492 of the 2022 Regular Legislature, as of August 1, 2022, the Louisiana Department of Health has assumed regulatory authority over Louisiana’s medical (therapeutic) marijuana program. LDH personnel are responsible for conducting inspections of medical marijuana production facilities and reviewing finished product test results to verify compliance with the requirements of La. R.S. 40: 1046. While there will be some changes to the way that the program is administered, the department is working with its counterparts at the Louisiana Department of Agriculture and Forestry to ensure a smooth transition.
The fundamental mechanics of the program remain unchanged at this time. There are two licensed medical-marijuana manufacturers in the state of Louisiana–the Louisiana State University Agricultural Center and the Southern University Agricultural Center. Each of those two licensees contracts with a third-party firm (“permittee”) to handle the aspects of growth, processing, testing and transportation of the product. Each batch of product is tested for purity and to ensure that it does not exceed the THC-content levels prescribed by the Legislature. Product that has been tested and accepted by the permittee may be transported to one of the (currently) ten licensed pharmacies/dispensaries in the state for distribution to a consumer. Dispensaries may provide medical marijuana in an approved dosage form to any patient with a valid recommendation from a board-certified Louisiana physician.
- regulatory authority over permitted manufacturers transferred to the Louisiana Department of Health (LDH) from the Louisiana Department of Agriculture and Forestry (LDAF)
- a patient-population-based mechanism is in place for licensed pharmacies (dispensaries) to open “satellite” locations
- third-party laboratory approval mechanism is in place for authorizing alternate laboratories for testing of medical-marijuana products (other than the LDAF Agricultural Chemistry Laboratory)
- explicitly authorizes physicians to recommend medical-marijuana patients by means of telemedicine appointments
Important Reference Docs
Medical Marijuana Regulation – emergency rules promulgated by the department
Act 491 of the 2022 Legislature – most recent statutory changes to the program (also see Act 492 and Act 628)
Act 492 of the 2022 Legislature – see Act 491 and Act 628
Act 628 of the 2022 Legislature – see Act 491 and Act 492
La. R.S. 40: 1046 – medical marijuana statute – note that this online version has not yet been updated with 2022 changes
- If you are a patient looking for a medical-marijuana recommendation (prescription), contact your primary-care physician.
- if you are a physician looking for the LSBME guidance regarding recommending therapeutic (medical) marijuana to patients, go here.
- if you are a pharmacy looking for rules on how to operate in compliance with Board of Pharmacy rules, go here.
Designated Medical Conditions (DMCs)
As of August 2018, the following are designated as DMCs:
- Parkinson’s disease
- positivestatus for human immunodeficiency virus
- acquired immune deficiency syndrome
- cachexia or wastingsyndrome
- seizure disorders
- severe muscle spasms
- intractable pain
- Crohn’s disease
- muscular dystrophy
- multiple sclerosis
- post-traumatic stress disorder
- and certain conditions associated withautism spectrum disorder e.g.: behavior of such severity that the physical health of the person with autism isjeopardized; avoidance of others or inability to communicate of such severity that the physical health of theperson with autism is jeopardized; self-injuring behavior; and physically aggressive or destructive behavior
With over 800+ current, peer reviewed citations, Medical Marijuana 411 is proud to be the global leader in online medical marijuana education for patients, medical professionals and dispensary consultants.
Additional videos from leading cited experts, scientists and physicians, and downloadable graphics are part of this certification. Here is a partial list of the scientists, researchers, educators and lawyers whose work is cited within the Medical Marijuana 411 certifications.
Our goal of creating the most current content for this cannabis certification course was obtained by using peer-reviewed research from industry experts. All citations utilized in this course meet standard guidelines and are part of the public domain. Experts listed below are not affiliated with Medical Marijuana 411 and no endorsement or authorization should be inferred by their inclusion on our website. Medical Marijuana 411 has included links to each expert to ensure credit is given for their research, legal and scientific studies under the guidelines of “Fair Use.”
Screen Shot 2022-10-05 at 3.56.37 PM
Screen Shot 2022-10-05 at 3.59.57 PM
Screen Shot 2022-10-05 at 3.59.28 PM
Screen Shot 2022-10-05 at 3.58.56 PM
Screen Shot 2022-10-05 at 3.58.15 PM
Screen Shot 2022-10-05 at 3.57.22 PM